Alteration of ghrelin/obestatin ratio in adolescence with polycystic ovarian syndrome

References

• Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223–36.
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219–31.
   PubMed Web of Science ®Google Scholar
• Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656–60.
   PubMed Web of Science ®Google Scholar
• Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000;141:4325–8.
   PubMed Web of Science ®Google Scholar
• van der Lely AJ, Tschöp M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004;25:426–57.
   PubMed Web of Science ®Google Scholar
• Schöfl C, Horn R, Schill T, et al. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:4607–10.
   PubMed Web of Science ®Google Scholar
• Mitkov M, Pehlivanov B, Orbetzova M. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters. Gynecol Endocrinol 2008;24:625–30.
   PubMed Web of Science ®Google Scholar
• Waśko R, Komarowska H, Warenik-Szymankiewicz A, Sowiński J. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome. Horm Metab Res 2004;36:170–3.
   PubMed Web of Science ®Google Scholar
• Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005;310:996–9.
   PubMed Web of Science ®Google Scholar
• Tang SQ, Jiang QY, Zhang YL, et al. Obestatin: its physicochemical characteristics and physiological functions. Peptides 2008;29:639–45.
   PubMed Web of Science ®Google Scholar
• Guo ZF, Zheng X, Qin YW, et al. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrinol Metab 2007;92:1875–80.
   PubMed Web of Science ®Google Scholar
• Li ZF, Guo ZF, Yang SG, et al. Circulating ghrelin and ghrelin to obestatin ratio are low in patients with untreated mild-to-moderate hypertension. Regul Pept 2010;165:206–9.
   PubMedGoogle Scholar
• Sultan C, Paris F. Clinical expression of polycystic ovary syndrome in adolescent girls. Fertil Steril 2006;86:S6.
   PubMed Web of Science ®Google Scholar
• Moran LJ, Lombard CB, Lim S, et al. Polycystic ovary syndrome and weight management. Womens Health (Lond Engl) 2010;6:271–83.
   PubMedGoogle Scholar
• Bekx MT, Connor EC, Allen DB. Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome. J Pediatr Adolesc Gynecol 2010;23:7–10.
   PubMed Web of Science ®Google Scholar
• Bhattacharya SM, Ghosh M. Insulin resistance and adolescent girls with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2010;23:158.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E. PCOS in adolescents. Best Pract Res Clin Obstet Gynaecol 2010;24:173–83.
   PubMed Web of Science ®Google Scholar
• Glintborg D, Andersen M, Hagen C, et al. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol 2006;155:337–45.
   PubMed Web of Science ®Google Scholar
• Barber TM, Casanueva FF, Karpe F, et al. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome. Eur J Endocrinol 2008;158:511–16.
   PubMed Web of Science ®Google Scholar
• Saad MF, Bernaba B, Hwu CM, et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002;87:3997–4000.
   PubMed Web of Science ®Google Scholar
• Bik W, Baranowska-Bik A, Wolinska-Witort E, et al. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome. Gynecol Endocrinol 2007;23:325–31.
   PubMed Web of Science ®Google Scholar
• Micic D, Sumarac-Dumanovic M, Kendereski A, et al. Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome. J Endocrinol Invest 2007;30:820–7.
   PubMed Web of Science ®Google Scholar
• Maha HD, Mazin HD, El-Mazny A. Circulating ghrelin levels and the polycystic ovary syndrome: correlation with the clinical, hormonal and metabolic features. Eur J Obstet Gynecol Reprod Biol 2011;155:65–8.
   PubMed Web of Science ®Google Scholar
• Egido EM, Hernández R, Marco J, Silvestre RA. Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas. Regul Pept 2009;152:61–6.
   PubMedGoogle Scholar
• Nogueiras R, Pfluger P, Tovar S, et al. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2007;148:21–6.
   PubMed Web of Science ®Google Scholar
• Ren AJ, Guo ZF, Wang YK, et al. Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem Biophys Res Commun 2008;369:969–72.
   PubMed Web of Science ®Google Scholar
• Green BD, Irwin N, Flatt PR. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 2007;28:981–7.
   PubMed Web of Science ®Google Scholar
• Panidis D, Farmakiotis D, Koliakos G, et al. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls. Hum Reprod 2005;20:2127–32.
   PubMed Web of Science ®Google Scholar
• Jackson VR, Nothacker HP, Civelli O. GPR39 receptor expression in the mouse brain. Neuroreport 2006;17:813–16.
   PubMed Web of Science ®Google Scholar
• Zamrazilová H, Hainer V, Sedlácková D, et al. Plasma obestatin levels in normal weight, obese and anorectic women. Physiol Res 2008;57:S49–55.
   PubMed Web of Science ®Google Scholar